Interview with the CFO: Medgenics Inc. (NYSEMKT:MDGN)

Healthcare >> CEO Interviews >> March 11, 2016

Brian Piper is Chief Financial Officer of Medgenics Inc. Mr. Piper was named Chief Financial Officer in February 2016 after joining Medgenics as VP, Finance and Investor Relations in April 2014. Prior to joining Medgenics, Mr. Piper served as Senior Director, Strategic Investment Group — SIG — for Shire Pharmaceuticals, LLC from 2010 to 2013, as well as several different finance and business development roles with Shire over the past 13 years. Mr. Piper began his affiliation with Shire in 2002 as Director of Finance for Shire's North American Development group in Rockville, Maryland. In 2004, he established Shire’s first U.S. Investor Relations group, based out of Philadelphia. After three years running U.S. Investor Relations, Mr. Piper transitioned to an alliance management role and spent two years overseas in Dublin, Ireland, helping establish geographic expansion strategies. Prior to joining Shire, Mr. Piper held strategic planning roles for Celera Genomics, was Controller for a startup contract research organization, and worked as a program planner and financial analyst for Otsuka Pharmaceuticals, Inc. Mr. Piper received a BBA from the University of Notre Dame and an MBA from the Robert H. Smith School of Business at the University of Maryland. Profile

TWST: Could you provide a brief history and overview of the company?

Mr. Piper: The company was founded over 15 years ago based on a gene therapy technology in Israel. The Founder and

Join for free to read a longer excerpt or purchase this article

Interview with the CFO: Medgenics Inc. (NYSEMKT:MDGN)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the CFO: Medgenics Inc. (NYSEMKT:MDGN)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS